Seven Fleet Capital Management LP
CIK 2092021 · View on SEC EDGAR ↗
- Portfolio value
- $384.5M
- Positions
- 96
- As of
- June 30, 2026
#4,467 of 9,443 by 13F value · top 47.3%
Portfolio value QoQ: +20.8% 13F does not disclose cash
- Top 10 holdings weight
- 54.52%
- Top 25 holdings weight
- 79.19%
- Positions above 1%
- 25
- Effective number of positions
- 20.5
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 14.06% Est. buys $217,853,006 · sells $49,407,673
- New positions
- 24
- Increased
- 36
- Decreased
- 27
- Closed
- 27
On this page
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
- Related The person behind this filer, where we can match one.
Sector breakdown
Healthcare
96.2%
Other/Unmapped
3.8%
Full portfolio 96 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics, Inc. - Common Stock | $54,443,081 | 14.16% | 1,909,593 | $43,940,990 | Up ×2 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $36,400,303 | 9.47% | 194,363 | $28,543,281 | Up ×2 | ||
| CGON CG Oncology, Inc. - Common stock | $31,748,195 | 8.26% | 446,843 | $26,620,894 | Up ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $14,836,369 | 3.86% | 111,334 | $10,042,529 | Up ×2 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $14,673,652 | 3.82% | 289,136 | $8,243,676 | Up ×2 | ||
| LQDA Liquidia Corporation - Common Stock | $14,519,072 | 3.78% | 182,103 | $7,428,632 | Down ×1 | ||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $12,923,709 | 3.36% | 110,393 | Up ×1 | |||
| PHVS Pharvaris N.V. - Ordinary Shares | $10,096,565 | 2.63% | 291,977 | $5,216,914 | Up ×2 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $10,072,866 | 2.62% | 118,240 | $6,034,626 | Up ×2 | ||
| TSHA Taysha Gene Therapies, Inc. - Common Stock | $9,940,323 | 2.59% | 1,504,400 | $7,143,408 | Up ×2 | ||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $8,567,092 | 2.23% | 246,606 | $7,407,778 | Up ×1 | ||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $8,104,441 | 2.11% | 438,552 | $4,912,123 | Up ×2 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $7,909,873 | 2.06% | 117,067 | $6,520,903 | Up ×2 | ||
| XNCR Xencor, Inc. - Common Stock | $7,828,524 | 2.04% | 368,305 | $6,863,724 | Up ×1 | ||
| ROIV Roivant Sciences Ltd. - Common Shares | $7,790,259 | 2.03% | 220,126 | $4,240,005 | Up ×1 | ||
| IPSC Century Therapeutics, Inc. - Common Stock | $7,222,174 | 1.88% | 2,947,826 | $560,087 | |||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $7,055,740 | 1.83% | 28,826 | $4,680,164 | Up ×2 | ||
| DFTX Definium Therapeutics, Inc. - Common Shares | $6,992,355 | 1.82% | 148,647 | $5,104,491 | Up ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $5,708,637 | 1.48% | 147,510 | $-41,731 | Down ×2 | ||
| ASMB Assembly Biosciences, Inc. - Common Stock | $5,680,995 | 1.48% | 206,732 | $4,122,915 | Up ×1 | ||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $5,565,132 | 1.45% | 45,400 | $5,143,532 | Up ×1 | ||
| EDIT Editas Medicine, Inc. - Common Stock | $4,310,820 | 1.12% | 1,330,500 | Up ×1 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $4,257,147 | 1.11% | 43,672 | $-296,184 | Down ×1 | ||
| GLTO Galecto, Inc. - Common Stock | $4,016,724 | 1.04% | 154,430 | $1,394,401 | Up ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $3,853,539 | 1.00% | 210,346 | $254,007 | Down ×1 | ||
| STRO Sutro Biopharma, Inc. - Common Stock | $3,794,182 | 0.99% | 159,118 | Up ×1 | |||
| RLAY Relay Therapeutics, Inc. - Common Stock | $3,334,534 | 0.87% | 178,222 | $770,041 | Down ×1 | ||
| Unknown issuer (CUSIP: K08588103) | $3,165,700 | 0.82% | 11,869 | Up ×1 | |||
| SGMT Sagimet Biosciences Inc. - Series A Common Stock | $3,119,403 | 0.81% | 403,545 | Up ×1 | |||
| ZLAB Zai Lab Limited - American Depositary Shares | $2,924,756 | 0.76% | 136,016 | $1,460,247 | Up ×1 | ||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $2,670,252 | 0.69% | 4,973 | $894,118 | Up ×2 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $2,610,802 | 0.68% | 70,164 | $1,681,406 | Up ×1 | ||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $2,524,317 | 0.66% | 7,540 | ||||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $2,409,994 | 0.63% | 348,265 | ||||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $2,212,929 | 0.58% | 334,785 | $-925,720 | Down ×1 | ||
| AGIO Agios Pharmaceuticals, Inc. - Common Stock | $2,111,559 | 0.55% | 56,900 | $-4,977,416 | Down ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $2,084,468 | 0.54% | 33,300 | Up ×1 | |||
| SVRA Savara, Inc. - Common Stock | $1,904,074 | 0.50% | 309,103 | $289,618 | Up ×2 | ||
| CCCC C4 Therapeutics, Inc. - Common Stock | $1,780,059 | 0.46% | 381,169 | $1,629,949 | Up ×1 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $1,777,570 | 0.46% | 29,800 | $-4,524,459 | Down ×1 | ||
| CELC Celcuity Inc. - Common Stock | $1,700,284 | 0.44% | 16,252 | $1,015,444 | Up ×1 | ||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $1,645,046 | 0.43% | 77,930 | Up ×1 | |||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $1,451,432 | 0.38% | 317,600 | $1,194,032 | Up ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $1,441,572 | 0.37% | 26,800 | $1,007,772 | Up ×1 | ||
| LONA LeonaBio, Inc. - Common Stock | $1,416,666 | 0.37% | 154,153 | $-276,203 | Down ×1 | ||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $1,411,229 | 0.37% | 37,865 | $-1,463,721 | Down ×1 | ||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $1,392,743 | 0.36% | 371,398 | $-352,828 | |||
| NERV Minerva Neurosciences, Inc - Common Stock | $1,370,717 | 0.36% | 246,976 | $-126,351 | Down ×1 | ||
| GERN Geron Corporation - Common Stock | $1,353,252 | 0.35% | 1,057,228 | $721,224 | Up ×1 | ||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $1,310,700 | 0.34% | 336,077 | $927,700 | Up ×1 | ||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $1,301,881 | 0.34% | 113,207 | Up ×1 | |||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $1,238,377 | 0.32% | 82,890 | $25,696 | |||
| MANE Veradermics, Incorporated Common Stock | $1,229,400 | 0.32% | 10,000 | Up ×1 | |||
| ALKS Alkermes plc - Ordinary Shares | $1,220,018 | 0.32% | 23,285 | $365,367 | Down ×1 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $1,180,774 | 0.31% | 13,300 | $187,610 | Down ×1 | ||
| CATX | $1,134,210 | 0.29% | 332,613 | $-446,562 | Down ×1 | ||
| OKUR OnKure Therapeutics, Inc. - Class A Common Stock | $1,098,791 | 0.29% | 240,963 | Up ×1 | |||
| SMMT Summit Therapeutics Inc. - Common Stock | $1,090,930 | 0.28% | 73,300 | Up ×1 | |||
| ANTX AN2 Therapeutics, Inc. - Common Stock | $1,011,299 | 0.26% | 208,946 | $328,322 | Up ×1 | ||
| CTNM Contineum Therapeutics, Inc. - Common stock | $992,267 | 0.26% | 60,541 | $638,942 | Up ×1 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $833,430 | 0.22% | 45,598 | $509,543 | Up ×2 | ||
| VYGR Voyager Therapeutics, Inc. - Common Stock | $771,860 | 0.20% | 230,406 | $327,176 | Up ×1 | ||
| IVA Inventiva S.A. - American Depository Shares | $756,533 | 0.20% | 200,141 | $-354,250 | |||
| Unknown issuer (CUSIP: 29286X101) | $711,142 | 0.18% | 411,065 | Up ×1 | |||
| LRMR Larimar Therapeutics, Inc. - Common Stock | $704,309 | 0.18% | 230,921 | $-450,324 | Down ×1 | ||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $704,207 | 0.18% | 346,900 | $157,199 | Up ×1 | ||
| NGNE Neurogene Inc. - Common Stock | $693,787 | 0.18% | 22,060 | Up ×1 | |||
| IHI | $681,858 | 0.18% | 13,800 | Up ×1 | |||
| SLN Silence Therapeutics Plc - American Depository Share | $659,975 | 0.17% | 60,107 | $-166,145 | Down ×1 | ||
| KRYS Krystal Biotech, Inc. - Common Stock | $659,343 | 0.17% | 1,774 | $-455,566 | Down ×1 | ||
| IRD Opus Genetics, Inc. - Common Stock | $588,293 | 0.15% | 143,137 | $-22,508 | Up ×1 | ||
| PALI Palisade Bio, Inc. - Common Stock | $568,906 | 0.15% | 272,204 | $195,981 | Up ×1 | ||
| EOLS Evolus, Inc. - Common Stock | $541,716 | 0.14% | 78,057 | $220,902 | |||
| UNCY Unicycive Therapeutics, Inc. - Common Stock | $521,136 | 0.14% | 103,400 | $154,630 | Up ×1 | ||
| CMPX Compass Therapeutics, Inc. - Common Stock | $510,415 | 0.13% | 233,066 | $-2,224,367 | Down ×2 | ||
| BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | $510,240 | 0.13% | 51,024 | $-465,493 | Down ×1 | ||
| DRUG Bright Minds Biosciences Inc. - common stock | $448,929 | 0.12% | 6,395 | $-17,715 | |||
| PRTA Prothena Corporation plc - Ordinary Shares | $423,907 | 0.11% | 43,300 | $3,031 | |||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $406,560 | 0.11% | 16,800 | $35,941 | Down ×1 | ||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $393,765 | 0.10% | 31,476 | Up ×1 | |||
| MIST Milestone Pharmaceuticals Inc. - Common Shares | $362,112 | 0.09% | 270,233 | $-34,554 | Down ×1 | ||
| ENTX Entera Bio Ltd. - Ordinary Shares | $338,697 | 0.09% | 191,354 | $110,545 | Down ×1 | ||
| Unknown issuer (CUSIP: 22978P205) | $337,755 | 0.09% | 10,702 | Up ×1 | |||
| MBX MBX Biosciences, Inc. - Common Stock | $331,200 | 0.09% | 6,000 | ||||
| BEAM Beam Therapeutics Inc. - Common Stock | $302,153 | 0.08% | 8,804 | $92,353 | |||
| AZN AstraZeneca PLC - American Depositary Shares | $265,468 | 0.07% | 1,400 | Up ×1 | |||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $261,138 | 0.07% | 14,540 | $29,411 | Down ×1 | ||
| STOK Stoke Therapeutics, Inc. - Common Stock | $255,353 | 0.07% | 7,745 | Up ×1 | |||
| VKTX Viking Therapeutics, Inc. - Common Stock | $251,884 | 0.07% | 7,404 | ||||
| LPCN Lipocine Inc. - Common Stock | $201,836 | 0.05% | 78,842 | $-796,451 | Down ×1 | ||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $201,032 | 0.05% | 21,432 | $-603,569 | Down ×1 | ||
| PMN ProMIS Neurosciences Inc. - Common Shares | $139,496 | 0.04% | 10,600 | $4,876 | |||
| WVE Wave Life Sciences Ltd. - Ordinary Shares | $99,812 | 0.03% | 19,048 | Up ×1 | |||
| PMVP PMV Pharmaceuticals, Inc. - Common Stock | $71,782 | 0.02% | 53,569 | $-6,956 | Down ×1 | ||
| FULC Fulcrum Therapeutics, Inc. - Common Stock | $66,206 | 0.02% | 18,089 | $-226,021 | Down ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $15,254 | 0.00% | 338 | ||||
| No matches | |||||||
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| MIRM | $12,923,709 | 110,393 | 3.36% |
| EDIT | $4,310,820 | 1,330,500 | 1.12% |
| STRO | $3,794,182 | 159,118 | 0.99% |
| Unknown issuer (CUSIP: K08588103) | $3,165,700 | 11,869 | 0.82% |
| SGMT | $3,119,403 | 403,545 | 0.81% |
| PRAX | $2,524,317 | 7,540 | 0.66% |
| RLMD | $2,409,994 | 348,265 | 0.63% |
| XENE | $2,084,468 | 33,300 | 0.54% |
| SNDX | $1,645,046 | 77,930 | 0.43% |
| ANL | $1,301,881 | 113,207 | 0.34% |
| MANE | $1,229,400 | 10,000 | 0.32% |
| OKUR | $1,098,791 | 240,963 | 0.29% |
| SMMT | $1,090,930 | 73,300 | 0.28% |
| Unknown issuer (CUSIP: 29286X101) | $711,142 | 411,065 | 0.18% |
| NGNE | $693,787 | 22,060 | 0.18% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| RVMD | Bought more | +114K | +$28.5M |
| ABVX | Bought more | +68K | +$10.0M |
| ELVN | Bought more | +125K | +$8.2M |
| LQDA | Trimmed | -6K | +$7.4M |
| TSHA | Bought more | +879K | +$7.1M |
| CYTK | Bought more | +57K | +$6.0M |
| PHVS | Bought more | +119K | +$5.2M |
| DFTX | Bought more | +49K | +$5.1M |
| AGIO | Trimmed | -153K | -$5.0M |
| AVTX | Bought more | +225K | +$4.9M |
6 positions hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| TYRA | June 30, 2026 | 195,685 | $7,494,736 | -18.9% |
| TERN | March 31, 2026 | 130,413 | $5,268,685 | No longer tracked |
| SLNO | June 30, 2026 | 115,770 | $3,875,980 | No longer tracked |
| EXEL | March 31, 2026 | 68,569 | $3,005,379 | 26.4% |
| ASND | June 30, 2026 | 12,179 | $2,785,703 | -2.8% |
| KALV | June 30, 2026 | 128,487 | $2,586,443 | No longer tracked |
| MLYS | June 30, 2026 | 69,571 | $1,884,678 | -2.9% |
| BLTE | March 31, 2026 | 9,161 | $1,465,394 | 6.3% |
| DYN | March 31, 2026 | 70,180 | $1,372,721 | 43.5% |
| FOLD | March 31, 2026 | 82,500 | $1,174,800 | No longer tracked |
| REPL | June 30, 2026 | 120,400 | $921,060 | 28.7% |
| MAZE | June 30, 2026 | 30,707 | $916,604 | -0.6% |
| CLYM | June 30, 2026 | 130,654 | $894,980 | 31.4% |
| CMPS | June 30, 2026 | 158,021 | $873,856 | -1.1% |
| ZURA | March 31, 2026 | 166,500 | $872,460 | -3.9% |
| PRAX | March 31, 2026 | 2,700 | $795,798 | 17.6% |
| RLMD | March 31, 2026 | 154,109 | $744,346 | -31.8% |
| DNLI | June 30, 2026 | 35,286 | $677,491 | -2.3% |
| UTHR | June 30, 2026 | 1,128 | $668,881 | -3.2% |
| CDTX | March 31, 2026 | 3,026 | $668,413 | No longer tracked |
| LLY | June 30, 2026 | 720 | $662,234 | 5.7% |
| VSTM | June 30, 2026 | 123,400 | $654,020 | 86.1% |
| MBX | March 31, 2026 | 18,200 | $574,028 | 123.4% |
| ZYME | March 31, 2026 | 20,600 | $542,398 | 6.5% |
| CNTX | June 30, 2026 | 190,785 | $499,857 | -11.0% |
| VRDN | March 31, 2026 | 14,654 | $456,032 | 23.5% |
| NTLA | June 30, 2026 | 31,500 | $403,830 | -25.1% |
| NRIX | March 31, 2026 | 20,000 | $379,400 | 74.0% |
| EWTX | June 30, 2026 | 11,701 | $368,582 | 10.4% |
| PLRX | March 31, 2026 | 276,500 | $337,330 | -7.1% |
| ACRS | March 31, 2026 | 107,419 | $323,331 | 70.7% |
| NKTR | June 30, 2026 | 4,300 | $309,385 | 7.2% |
| SEPN | June 30, 2026 | 11,445 | $275,023 | 29.1% |
| OCUL | June 30, 2026 | 31,296 | $265,077 | 16.6% |
| NUVL | June 30, 2026 | 2,072 | $212,276 | No longer tracked |
| VKTX | March 31, 2026 | 6,000 | $211,080 | 6.2% |
| QURE | March 31, 2026 | 8,742 | $209,196 | 193.0% |
| IRON | June 30, 2026 | 3,231 | $206,590 | 8.5% |
| WHWK | June 30, 2026 | 54,296 | $187,321 | 5.2% |
| INBX | June 30, 2026 | 2,482 | $166,865 | 4.5% |
| APGE | June 30, 2026 | 1,969 | $165,731 | 1.5% |
| ORKA | March 31, 2026 | 5,240 | $158,824 | 118.1% |
| NAMS | March 31, 2026 | 4,000 | $140,320 | -12.7% |
| ALXO | March 31, 2026 | 117,817 | $133,133 | 0.0% |
| PEPG | June 30, 2026 | 59,500 | $105,315 | 73.4% |
| RGC | March 31, 2026 | 4,400 | $92,400 | -77.3% |
| IMUX | March 31, 2026 | 155,223 | $82,843 | 1391.0% |
| TRAW | March 31, 2026 | 49,260 | $55,664 | -70.6% |
| ATXS | March 31, 2026 | 4,000 | $52,360 | No longer tracked |
| VTGN | March 31, 2026 | 62,701 | $41,502 | -57.9% |
| MGNX | June 30, 2026 | 13,387 | $38,688 | -10.1% |
| ENTA | March 31, 2026 | 2,270 | $35,798 | 6.8% |
| GBIO | March 31, 2026 | 5,376 | $30,536 | No longer tracked |
| CGEM | June 30, 2026 | 1,844 | $26,203 | 19.5% |
| ELDN | March 31, 2026 | 6,000 | $9,060 | 14.6% |
| VIR | March 31, 2026 | 200 | $1,206 | 5.8% |